SineuGene gets China NMPA & US FDA nods to initiate phase I/IIa trial of gene therapy, SNUG01 to treat amyotrophic lateral sclerosis: Beijing Monday, August 18, 2025, 18:00 Hrs [I ...

Australia’s Neurizon Therapeutics saw its shares rise 10% to A$0.16 today. after it revealed that it has been informed by the ...

BCLI READ THE FULL BCLI RESEARCH REPORT Business Update Focused on Advancing NurOwn into Phase 3b ENDURANCE Trial BrainStorm ...

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that causes the gradual loss of motor neurons in the brain and spinal cord, leading to muscle weakness, paralysis, and ...

Former Leafs posted the news Sunday evening. Kirton, 67, was diagnosed with amyotrophic lateral sclerosis, or Lou Gehrig’s ...

A new brain-computer interface technology can decode a user’s inner monologue, an advance that scientists say can help ...

In the beginning, not even Hynek Wichterle's postdoc thought his idea to slow the progression of amyotrophic lateral ...

Stone will be joining Dane — whom she has been friends with "for a long time" — on the long-awaited third season of the HBO ...

Long-term exposure to sulfur dioxide, an air pollutant generated by the burning of fossil fuels, increases the risk of ALS, a ...

Tommy and Vickie Smith have faced more than their share of health challenges. Tommy has been living with amyotrophic lateral ...

A new discovery about mutations in a gene that causes ALS may allow researchers to design targeted therapies, a study found.

Answer ALS, in collaboration with ALS Therapy Development Institute (ALS TDI) and Augie's Quest, today announced plans to ...